期刊文献+

PET-CT在非小细胞肺癌诊疗中的应用 被引量:2

Diagnostic and therapeutic values of PET-CT in non-small cell lung cancer
下载PDF
导出
摘要 PET-CT是利用正电子放射性示踪剂显示活体组织器官内生化状态的显像技术。它以18F-氟代脱氧葡萄糖(18F-FDG)为最常用的放射性显像剂,具有灵敏性高、特异性强及定位精确等特点,是目前较为理想的肿瘤检测手段。文中就PET-CT在非小细胞肺癌(Non-small cell lung cancer,NSCLC)诊断中的应用作一概述。 Positron emission tomography-computed tomography(PET-CT) is an imaging technique by obtaining images through previous intravenous administration of F18-FDG.Owing to its advantages of higher sensitivity,specificity and precise positioning,PET-CT is considered as an excellent method for detecting malignant tumors.In this review,we discuss its role in the diagnosis of non-small cell lung cancer(NSCLC).
出处 《医学研究生学报》 CAS 2011年第8期874-878,共5页 Journal of Medical Postgraduates
基金 江苏省卫生厅科技项目课题(H200873)
关键词 正电子发射计算机断层扫描 18F-氟代脱氧葡萄糖 非小细胞肺癌 PET-CT 18F-FDG Non-small cell lung cancer
  • 相关文献

参考文献6

二级参考文献19

  • 1He J,Gu D,Wu X,et al.Major causes of death among men and women in China[J].N Engl J Med,2005,353(11):1124-1134. 被引量:1
  • 2Vansteenkiste JF,Stroobants SG,Dupont PJ,et al.Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer:An analysis of 125 cases.Leuven Lung Cancer Group[J].J Clin Oncol,1999,17(10):3201-3206. 被引量:1
  • 3Ahuja V,Coleman RE,Herndon J,et al.The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma[J].Cancer,1998,83(5):918-924. 被引量:1
  • 4Pauwels EK,McCready VR,Stoot JH,et al.The mechanism of accumulation of tumour-localising radiopharmaceuticals[J].Eur J Nucl Med,1998,25(3):277-305. 被引量:1
  • 5Kramer H,Post WJ,Pruim J,et al.The prognostic value of positron emission tomography in non-small cell lung cancer:analysis of 266 cases[J].Lung Cancer,2006,52(2):213-217. 被引量:1
  • 6Berghmans T,Dusart M,Paesmans M,et al.Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC):A systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project[J].J Thorac Oncol,2008,3(1):6-12. 被引量:1
  • 7Kim TY, Yang SH, Lee SH, et al. A phase Ⅲ randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer. Am J Clin Oncol,2002,25(3): 238-243. 被引量:1
  • 8Morris DE, Rosenman JG, Halle JS, et al.Induction chemotherapy followed by doseescalated thoracic 3 dimensional conformal radiation therapy to 90 Gy with concurrent chemotherapy in stage Ⅲ A/B non-small cell lung cancer: a phase Ⅰ radiation dose escalation trial. Int J Radiat Oncol Biol Phys,2003,57(2 Suppl): S138-S139. 被引量:1
  • 9Chemotherapy in non small cell lung cancer:a meta-analysis using updated data on indi vidual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ,1995,311(7010) : 899-909. 被引量:1
  • 10Le Chevalier T, for the IALT Investigators.Results of the Randomized International Ad juvant Lung Cancer Trial (IALT): cisplatinbased chemotherapy (CT) vs no CT in 1867patients (pts) with resected non small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol,2003,23(abstr. 6). 被引量:1

共引文献41

同被引文献11

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部